Guild aiming to resolve “remaining issues of contention” in “good faith” as 8CPA deadline looms  Progress is being made to deliver the Eighth Community Pharmacy Agreement (8CPA), but more urgency …

Investment in a community pharmacy initiative would help ensure priority access to palliative medicines and personal care supplies after hours, one group says As part of its 2024-5 pre-Budget submission, …

As the scope and range of pharmacist-administered medicines by injection evolves around the country, so too does the level of responsibility and potential risk to the administering pharmacist, and to …

PDL has some advice on common incidents involving the Opioid Therapy Program, following last year’s changes Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program …

Amid a continued staff shortage at Royal Hobart Hospital’s pharmacy department, programs like Partnered Pharmacist Medication Charting are being slashed – putting patients at risk The Health and Community Services …

Minister says government is committed to ensuring affordable access to ODT  Transitional arrangements for patients undergoing opioid dependence treatment (ODT) with private providers will remain in place until 30 June …

Shopping centre landlords raise concerns about pharmacy tenants launching opioid dependence treatment and needle and syringe programs  Proposed legislation surrounding pharmacy ownership in Queensland needs to be amended to prevent …

Work health and safety (WHS) regulations requiring businesses to manage psychosocial hazards have been in effect since 2022. A community pharmacist and an employment lawyer discuss implications for pharmacy 5 …

When it was seized at the border, a pharmacist tried to claim that a shipment of unlawfully imported Phosphatidylcholine was for her personal use A Stage One hearing before the …

Debbie Rigby takes a look at the latest in research news Management of type 2 diabetes in patients with frailty Newer antihyperglycemic agents such as glucagonlike peptide-1 receptor agonists (GLP1-RAs), …

Global medicinal cannabis giant targets Australian market with MedReleaf takeover  Canada’s Aurora Cannabis is eyeing significant grow in Australia through its acquisition of MedReleaf Australia.   In a statement to …

ASX issues pharmacy technology provider, PharmX with a price query after share price plunged 66% in early trading  Pharmacy ordering and invoicing platform provider, PharmX (formerly Corum Health) has told …